Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
17β-Estradiol is a naturally occurring estrogen steroid hormone and the major female sex hormone in humans, vital for the development and maintenance of female reproductive tissues and secondary sexual characteristics. It exerts its physiological effects primarily by binding to estrogen receptors (ERα and ERβ), modulating gene expression and cellular signaling processes in multiple tissues. Estradiol is also involved in rapid nongenomic signal transduction and influences cardiovascular, bone, nervous, and immune systems. In medical practice, estradiol itself is used as a drug for hormone replacement, but as a molecule, it is not a "target" for drug action; rather, it is the ligand for target proteins (the estrogen receptors). Thus, references to "targeting" estradiol generally relate to either antagonizing its effects (through receptor blockade) or inhibiting its synthesis.
Estradiol binds to and activates estrogen receptors (ERα, ERβ), which are nuclear transcription factors, leading to gene regulation and cellular responses. It also acts via rapid, nongenomic pathways involving kinase signaling cascades.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Estradiol (specifically, 17β-estradiol) (E2).